Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?
Irvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. It is valued at a market cap of $45.9 billion. This healthcare company has considerably underperformed the broader market over the past 52 weeks. Shares of EW have gained 7.8% over this time frame, while the broader S&P 500 Index ($SPX) has soared…
